Prescription pattern of anti-Parkinson's disease drugs in Japan based on a nationwide medical claims database.

导出 LinkOut

翻译打印收藏纠错

作者： Masahiko,Suzuki ^[1] ; Masaki,Arai ^[2] ; Ayako,Hayashi ^[2] ; Mieko,Ogino ^[3]

作者单位： Department of Neurology, The Jikei University Katsushika Medical Center, Tokyo, Japan. ^[1] Japan Medical Affairs, Takeda Pharmaceutical Company Limited, Tokyo, Japan. ^[2] International University of Health and Welfare, School of Medicine, Center for Medical Education, Narita, Japan. ^[3]

关键词 Anti-Parkinson's disease drug COMT, catechol-O-methyltransferase Cross-sectional study DA, dopamine agonist DPC/PDPS, Japanese Diagnosis Procedure Combination/Per-Diem Payment System GPP3, Good Publication Practice 3 Health insurance claims data ICD-10, International Classification of Disease, Tenth Revision Japan L-dopa, levodopa MAO-B, monoamine oxidase-B MDV, Medical Data Vision PD, Parkinson's disease Parkinson's disease Prescription pattern

DOI 10.1016/j.ensci.2020.100257

PMID 32775705

发布时间 2022-04-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

eNeurologicalSci

2020年20卷

100257页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Prescription pattern of anti-Parkinson's disease drugs in Japan based on a nationwide medical claims database.

eNeurologicalSci

相似文献

eNeurologicalSci

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Prescription pattern of anti-Parkinson's disease drugs in Japan based on a nationwide medical claims database.

eNeurologicalSci

相似文献

eNeurologicalSci

相关期刊

检索历史清除